Knowledge about the biological origin of diseases like schizophrenia, bipolar disorder and other psychiatric conditions is critical to improving diagnosis and treatment.
Nelson Freimer, professor of psychiatry and director of UCLA’s center for neurobehavioral genetics, was quoted in the April 3 New York Times about an Alzheimer’s study that discovered five genes offering new clues to why the disease strikes and how it progresses.
Schizophrenia is a severe psychiatric disease characterized by disorganized behavior, delusions and hallucinations. Sadly, there is no clear understanding of its cause. Now, in a collaborative study, UCLA and Dutch researchers have identified three new candidate genes for schizophrenia that may contribute to a better understanding of how the disease evolves.
The National Institute of Mental Health has awarded Roel A. Ophoff, Ph.D., assistant professor of human genetics at the David Geffen School of Medicine at UCLA, a $3.8 million grant to lead a four-year genetic study of schizophrenia in collaboration with scientists from the University Medical Center (UMC) Utrecht in the Netherlands.
Disruptions also found in cellular pathways involved in memory and cognition
If humans are genetically related to chimps, why did our brains develop the innate ability for language and speech while theirs did not?
UCLA scientists have identified a molecular switch that prevents Huntington's disease from developing in mice. Published in the Dec. 24 edition of the journal Neuron, the discovery suggests a new approach to treating the genetic disorder, which ultimately leads to death in as little as 10 years.